BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010;8:213-219. [PMID: 19835989 DOI: 10.1016/j.cgh.2009.10.001] [Cited by in Crossref: 213] [Cited by in F6Publishing: 187] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Pinho DF, Rofsky NM, Pedrosa I. Incidental pancreatic cysts: role of magnetic resonance imaging. Top Magn Reson Imaging. 2014;23:117-128. [PMID: 24690615 DOI: 10.1097/rmr.0000000000000018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Paini M, Crippa S, Partelli S, Scopelliti F, Tamburrino D, Baldoni A, Falconi M. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol 2014; 20(29): 10008-10023 [PMID: 25110429 DOI: 10.3748/wjg.v20.i29.10008] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
3 Das KK, Early D. Pancreatic cancer screening. Curr Treat Options Gastroenterol. 2017;15:562-575. [PMID: 28879469 DOI: 10.1007/s11938-017-0149-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Jani N, Bani Hani M, Schulick RD, Hruban RH, Cunningham SC. Diagnosis and management of cystic lesions of the pancreas. Diagn Ther Endosc. 2011;2011:478913. [PMID: 21904442 DOI: 10.1155/2011/478913] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
5 Dumlu EG, Karakoç D, Özdemir A. Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives. Int Surg. 2015;100:1060-1068. [PMID: 26414828 DOI: 10.9738/INTSURG-D-14-00220.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Sahani DV, Kambadakone A, Macari M, Takahashi N, Chari S, Fernandez-del Castillo C. Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol. 2013;200:343-354. [PMID: 23345356 DOI: 10.2214/ajr.12.8862] [Cited by in Crossref: 88] [Cited by in F6Publishing: 29] [Article Influence: 9.8] [Reference Citation Analysis]
7 Crippa S, Piccioli A, Salandini MC, Cova C, Aleotti F, Falconi M. Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art. Updates Surg 2016;68:265-71. [PMID: 27502606 DOI: 10.1007/s13304-016-0386-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Detlefsen S, Jakobsen M, Nielsen MFB, Klöppel G, Mortensen MB. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm. Pathol Res Pract 2021;217:153312. [PMID: 33341087 DOI: 10.1016/j.prp.2020.153312] [Reference Citation Analysis]
9 Muniraj T, Aslanian HR, Laine L, Jamidar PA, Farrell JF, Mitchell KA, Salem RR. Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies. World J Gastroenterol 2021; 27(15): 1630-1642 [PMID: 33958848 DOI: 10.3748/wjg.v27.i15.1630] [Reference Citation Analysis]
10 Crippa S, Falconi M. Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts--a shape shifting outlook into an increasingly recognized disease. Dig Liver Dis 2012;44:183-4. [PMID: 22265327 DOI: 10.1016/j.dld.2011.12.015] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Yamane A, Sadahiro H, Goto H, Inamura A, Ishihara H, Oka F, Oku T, Kondo T, Suzuki M. Multiple ischemic strokes caused by nonbacterial thrombotic endocarditis because of gallbladder cancer: a case report. J Stroke Cerebrovasc Dis 2014;23:1727-9. [PMID: 24582789 DOI: 10.1016/j.jstrokecerebrovasdis.2013.12.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Lester C, Walsh L, Hartz KM, Mathew A, Levenick JM, Headlee BD, Heisey HD, Birkholz JH, Dixon M, Maranki JL, Gusani NJ, Dye CE, Moyer MT. The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00351-7. [PMID: 33813070 DOI: 10.1016/j.cgh.2021.03.041] [Reference Citation Analysis]
13 Crippa S, Partelli S, Falconi M. Questions about branch-duct IPMNs with Sendai negative criteria. Ann Surg 2014;259:e42. [PMID: 24253153 DOI: 10.1097/SLA.0000000000000208] [Reference Citation Analysis]
14 Schlitter AM, Esposito I. [Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas]. Chirurg. 2012;83:110-115. [PMID: 22271052 DOI: 10.1007/s00104-011-2181-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Roch AM, Schmidt CM. Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm. Advances in Surgery 2016;50:1-15. [DOI: 10.1016/j.yasu.2016.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Mino-Kenudson M, Fernández-del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, Correa-Gallego C, Ingkakul T, Perez Johnston R, Turner BG. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712-1720. [PMID: 21508421 DOI: 10.1136/gut.2010.232272] [Cited by in Crossref: 178] [Cited by in F6Publishing: 164] [Article Influence: 16.2] [Reference Citation Analysis]
17 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789-804. [PMID: 29574408 DOI: 10.1136/gutjnl-2018-316027] [Cited by in Crossref: 380] [Cited by in F6Publishing: 283] [Article Influence: 95.0] [Reference Citation Analysis]
18 Abdeljawad K, Vemulapalli KC, Schmidt CM, Dewitt J, Sherman S, Imperiale TF, Al-Haddad M. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014;79:623-629. [PMID: 24094923 DOI: 10.1016/j.gie.2013.08.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
19 Jana T, Shroff J, Bhutani MS. Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options. J Carcinog. 2015;14:3. [PMID: 25821410 DOI: 10.4103/1477-3163.153285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Li J, Wei T, Zhang J, Liang T. Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models. Cancers (Basel) 2021;13:5296. [PMID: 34771461 DOI: 10.3390/cancers13215296] [Reference Citation Analysis]
21 Al Efishat M, Allen PJ. Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am 2016;25:351-61. [PMID: 27013369 DOI: 10.1016/j.soc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
22 Yu S, Takasu N, Watanabe T, Fukumoto T, Okazaki S, Tezuka K, Sugawara S, Hirai I, Kimura W. Validation of the 2012 Fukuoka Consensus Guideline for Intraductal Papillary Mucinous Neoplasm of the Pancreas From a Single Institution Experience. Pancreas 2017;46:936-42. [PMID: 28697135 DOI: 10.1097/MPA.0000000000000874] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Salvia R, Crippa S, Partelli S, Armatura G, Malleo G, Paini M, Pea A, Bassi C. Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2010; 2(10): 342-346 [PMID: 21160841 DOI: 10.4240/wjgs.v2.i10.342] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
24 Morris-Stiff G, Falk GA, Chalikonda S, Walsh RM. Natural history of asymptomatic pancreatic cystic neoplasms. HPB (Oxford) 2013;15:175-81. [PMID: 23374357 DOI: 10.1111/j.1477-2574.2012.00522.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
25 Suzuki Y, Nakazato T, Yokoyama M, Kogure M, Matsuki R, Abe N, Mori T, Ohkura Y, Sugiyama M. Development and Potential Utility of a New Scoring Formula for Prediction of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016;45:1227-32. [DOI: 10.1097/mpa.0000000000000649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
26 Koh YX, Chok AY, Zheng HL, Tan CS, Goh BK. Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2014;21:2782-2800. [PMID: 24687151 DOI: 10.1245/s10434-014-3639-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
27 Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management. Scandinavian Journal of Gastroenterology 2017;52:803-15. [DOI: 10.1080/00365521.2017.1318948] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
28 Basar O, Brugge WR. My Treatment Approach: Pancreatic Cysts. Mayo Clin Proc. 2017;92:1519-1531. [PMID: 28890216 DOI: 10.1016/j.mayocp.2017.06.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
29 Fernández-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139:708-713; 713.e1-2. [PMID: 20650278 DOI: 10.1053/j.gastro.2010.07.025] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 9.4] [Reference Citation Analysis]
30 Spence RA, Dasari B, Love M, Kelly B, Taylor M. Overview of the Investigation and Management of Cystic Neoplasms of the Pancreas. Dig Surg 2011;28:386-97. [DOI: 10.1159/000334758] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 Italian Association of Hospital Gastroenterologists and Endoscopists, Italian Association for the Study of the Pancreas, Cystic Pancreatic Neoplasm Study Group; Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46:479-493. [PMID: 24809235 DOI: 10.1016/j.dld.2013.12.019] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
32 Kim TS, Fernandez-del Castillo C. Diagnosis and Management of Pancreatic Cystic Neoplasms. Hematol Oncol Clin North Am 2015;29:655-74. [PMID: 26226903 DOI: 10.1016/j.hoc.2015.04.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
33 Hernandez YG, Lucas AL. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. World J Gastrointest Oncol 2016; 8(1): 18-29 [PMID: 26798434 DOI: 10.4251/wjgo.v8.i1.18] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
34 Tanaka M, Fernández-del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-53. [DOI: 10.1016/j.pan.2017.07.007] [Cited by in Crossref: 574] [Cited by in F6Publishing: 463] [Article Influence: 114.8] [Reference Citation Analysis]
35 Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Castillo CF. Patterns of Recurrence After Resection of IPMN: Who, When, and How? Ann Surg. 2015;262:1108-1114. [PMID: 25793719 DOI: 10.1097/sla.0000000000001008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 26] [Article Influence: 11.2] [Reference Citation Analysis]
36 Scholten L, van Huijgevoort NCM, van Hooft JE, Besselink MG, Del Chiaro M. Pancreatic Cystic Neoplasms: Different Types, Different Management, New Guidelines. Visc Med. 2018;34:173-177. [PMID: 30182024 DOI: 10.1159/000489641] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Fritz S, Lerch MM. Natural History and Management of Intraductal Papillary Mucinous Neoplasms: Current Evidence. Viszeralmedizin 2015;31:25-30. [PMID: 26288612 DOI: 10.1159/000375186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
38 Rossi RE, Massironi S. Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. Expert Rev Gastroenterol Hepatol 2018;12:1123-33. [PMID: 30264593 DOI: 10.1080/17474124.2018.1530111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
39 Gausman V, Kandel P, Van Riet PA, Moris M, Kayal M, Do C, Poneros JM, Sethi A, Gress FG, Schrope BA, Luk L, Hecht E, Jovani M, Bruno MJ, Cahen DL, Wallace MB, Gonda TA. Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort. Pancreas 2018;47:471-6. [PMID: 29521942 DOI: 10.1097/MPA.0000000000001027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Giuffrida P, Biagiola D, Ardiles V, Uad P, Palavecino M, de Santibañes M, Clariá RS, Pekolj J, de Santibañes E, Mazza O. Long-term follow-up of Branch-Duct Intraductal Papillary Mucinous Neoplasms with negative Sendai Criteria: the therapeutic challenge of patients who convert to positive Sendai Criteria. HPB (Oxford) 2021;23:290-300. [PMID: 32709558 DOI: 10.1016/j.hpb.2020.06.011] [Reference Citation Analysis]
41 de Wilde RF, Hruban RH, Maitra A, Offerhaus GJA. Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm. Diagnostic Histopathology 2012;18:17-30. [DOI: 10.1016/j.mpdhp.2011.10.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
42 Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, Mckay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R, Abakken L, Adham M, Albin N, Andren-sandberg Å, Arnelo U, Bruno M, Cahen D, Cappelli C, Costamagna G, Del Chiaro M, Delle Fave G, Esposito I, Falconi M, Friess H, Ghaneh P, Gladhaug I, Haas S, Hauge T, Izbicki J, Klöppel G, Lerch M, Lundell L, Lüttges J, Löhr M, Manfredi R, Mayerle J, Mckay C, Oppong K, Pukitis A, Rangelova E, Rosch T, Salvia R, Schulick R, Segersvärd R, Sufferlein T, Van Cutsem E, Van der Merwe S, Verbeke C, Werner J, Zamboni G. European experts consensus statement on cystic tumours of the pancreas. Digestive and Liver Disease 2013;45:703-11. [DOI: 10.1016/j.dld.2013.01.010] [Cited by in Crossref: 286] [Cited by in F6Publishing: 234] [Article Influence: 31.8] [Reference Citation Analysis]
43 Efthymiou A, Podas T, Zacharakis E. Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms. World J Gastroenterol 2014; 20(24): 7785-7793 [PMID: 24976716 DOI: 10.3748/wjg.v20.i24.7785] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Poiraud C, El Amrani M, Barbier L, Chiche L, Mabrut JY, Bachellier P, Pruvot F, Delpero J, Tuech JJ, Adham M, Sauvanet A, Turrini O, Truant S. Total Pancreatectomy for Presumed Intraductal Papillary Mucinous Neoplasms: A Multicentric Study of the French Surgical Association (AFC). Annals of Surgery 2018;268:823-30. [DOI: 10.1097/sla.0000000000002944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Amateau SK, Fukami N. Intraductal papillary mucinous neoplasm of the pancreas: changing perspective of the impact of surgery on patient outcome. Clin Gastroenterol Hepatol. 2014;12:492-495. [PMID: 24246769 DOI: 10.1016/j.cgh.2013.11.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Hanania AN, Bantis LE, Feng Z, Wang H, Tamm EP, Katz MH, Maitra A, Koay EJ. Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. 2016;7:85776-85784. [PMID: 27588410 DOI: 10.18632/oncotarget.11769] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 19.0] [Reference Citation Analysis]
47 Piciucchi M, Crippa S, Del Chiaro M, Valente R, Pezzilli R, Falconi M, Delle Fave G, Capurso G. Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. Dig Liver Dis. 2013;45:584-588. [PMID: 23453065 DOI: 10.1016/j.dld.2013.01.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
48 Postlewait LM, Ethun CG, McInnis MR, Merchant N, Parikh A, Idrees K, Isom CA, Hawkins W, Fields RC, Strand M, Weber SM, Cho CS, Salem A, Martin RC, Scoggins C, Bentrem D, Kim HJ, Carr J, Ahmad S, Abbott DE, Wilson GC, Kooby DA, Maithel SK. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg 2017;152:19-25. [PMID: 27760255 DOI: 10.1001/jamasurg.2016.3598] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 7.4] [Reference Citation Analysis]
49 Pulvirenti A, Marchegiani G, Malleo G, Borin A, Allegrini V, Bassi C, Salvia R. Cystic Neoplasm of the Pancreas. Indian J Surg 2015;77:387-92. [PMID: 26722201 DOI: 10.1007/s12262-015-1363-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Maggi G, Guarneri G, Gasparini G, Fogliati A, Partelli S, Falconi M, Crippa S. Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy? Endosc Ultrasound 2018;7:319-22. [PMID: 30323161 DOI: 10.4103/eus.eus_44_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Sahora K, Fernández-del Castillo C, Dong F, Marchegiani G, Thayer SP, Ferrone CR, Sahani DV, Brugge WR, Warshaw AL, Lillemoe KD, Mino-Kenudson M. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery 2014;156:611-21. [PMID: 25081232 DOI: 10.1016/j.surg.2014.04.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
52 Levink I, Bruno MJ, Cahen DL. Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives. Curr Treat Options Gastroenterol. 2018;16:316-332. [PMID: 30196428 DOI: 10.1007/s11938-018-0190-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
53 D'Haese JG, Werner J. Surgery of Cystic Tumors of the Pancreas - Why, When, and How? Visc Med 2018;34:206-10. [PMID: 30182025 DOI: 10.1159/000489234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
54 Panteleev VI, Gorin DS, Kaldarov AR, Kriger AG. Intraductal papillary mucinous neoplasm of pancreas. Khir Z im N I Pirogova 2019. [DOI: 10.17116/hirurgia201911181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
55 Wu W, Hong X, Tian R, You L, Dai M, Liao Q, Zhang T, Zhao Y. An increased total resected lymph node count benefits survival following pancreas invasive intraductal papillary mucinous neoplasms resection: an analysis using the surveillance, epidemiology, and end result registry database. PLoS One 2014;9:e107962. [PMID: 25264746 DOI: 10.1371/journal.pone.0107962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Honselmann KC, Krauss T, Geserick S, Wellner UF, Wittel U, Hopt UT, Keck T, Bausch D. Cystic lesions of the pancreas—is radical surgery really warranted? Langenbecks Arch Surg 2016;401:449-56. [DOI: 10.1007/s00423-016-1416-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
57 Krieger AG, Karmazanovskiy GG, Panteleev VI, Gorin DS, Vetsheva NN, Berelavichus SV, Kaldarov AR, Glotov AV. [Diagnostic and treatment of the intraductal papillary mucinous tumor of pancreas]. Khirurgiia (Mosk) 2020;:14-24. [PMID: 31994495 DOI: 10.17116/hirurgia202001114] [Reference Citation Analysis]
58 Torphy RJ, Schulick RD. Screening of Patients at Risk for Familial Pancreatic Cancer. Surgical Clinics of North America 2018;98:25-35. [DOI: 10.1016/j.suc.2017.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
59 Jang DK, Ryu JK, Chung KH, Lee BS, Park JK, Lee SH, Kim Y. Risk Factors for Progression or Malignancy in Main-Duct and Mixed-Type Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016;45:1027-31. [DOI: 10.1097/mpa.0000000000000592] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
60 Barresi L, Tarantino I, Granata A, Curcio G, Traina M. Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle. World J Gastrointest Endosc 2012; 4(6): 247-259 [PMID: 22720127 DOI: 10.4253/wjge.v4.i6.247] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
61 Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Dig Dis Sci 2017;62:1808-15. [PMID: 28315030 DOI: 10.1007/s10620-017-4544-8] [Reference Citation Analysis]
62 Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, Büchler MW. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg. 2014;260:848-855; discussion 855-856. [PMID: 25379856 DOI: 10.1097/sla.0000000000000980] [Cited by in Crossref: 77] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
63 Gerry JM, Poultsides GA. Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection. Dig Dis Sci. 2017;62:1816-1826. [PMID: 28421458 DOI: 10.1007/s10620-017-4570-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
64 Cobo I, Iglesias M, Flández M, Verbeke C, Del Pozo N, Llorente M, Lawlor R, Luchini C, Rusev B, Scarpa A, Real FX. Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions. J Pathol 2021;253:174-85. [PMID: 33079429 DOI: 10.1002/path.5570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Fischer CG, Wood LD. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. J Pathol 2018;246:395-404. [PMID: 30105857 DOI: 10.1002/path.5154] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
66 Shi C, Hruban RH. Intraductal papillary mucinous neoplasm. Hum Pathol. 2012;43:1-16. [PMID: 21777948 DOI: 10.1016/j.humpath.2011.04.003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
67 Crippa S, Partelli S, Tamburrino D, Falconi M. The natural history of a branch-duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2014;155:578-9. [DOI: 10.1016/j.surg.2012.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
68 Ingkakul T, Warshaw AL, Fernández-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Pancreas 2011;40:779-80. [PMID: 21673537 DOI: 10.1097/MPA.0b013e31821f27fb] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
69 Paini M, Crippa S, Scopelliti F, Baldoni A, Manzoni A, Belfiori G, Partelli S, Falconi M. Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs. Gastroenterol Res Pract 2014;2014:269803. [PMID: 25276122 DOI: 10.1155/2014/269803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
70 Park JY, Lee JH, Song KB, Hwang DW, Kim KR, Kim SC, Hong SM. Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas. Hum Pathol 2018;78:18-27. [PMID: 29410139 DOI: 10.1016/j.humpath.2018.01.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Rezaee N, Khalifian S, Cameron JL, Pawlik TM, Hruban RH, Fishman EK, Makary MA, Lennon AM, Wolfgang CL, Weiss MJ. Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms. J Gastrointest Surg 2015;19:656-65. [PMID: 25477314 DOI: 10.1007/s11605-014-2714-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
72 Farrell JJ, Fernández-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144:1303-1315. [PMID: 23622140 DOI: 10.1053/j.gastro.2013.01.073] [Cited by in Crossref: 159] [Cited by in F6Publishing: 121] [Article Influence: 17.7] [Reference Citation Analysis]
73 Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw A, Lillemoe K, Mino-kenudson M, Falconi M, Fernandez-del Castillo C. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. European Journal of Surgical Oncology (EJSO) 2016;42:197-204. [DOI: 10.1016/j.ejso.2015.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
74 Crippa S, Belfiori G, Tamburrino D, Partelli S, Falconi M. Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground. Updates Surg 2021;73:1219-29. [PMID: 34331677 DOI: 10.1007/s13304-021-01141-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Watanabe Y, Nishihara K, Niina Y, Abe Y, Amaike T, Kibe S, Mizuuchi Y, Kakihara D, Ono M, Tamiya S, Toyoshima S, Nakano T, Mitsuyama S. Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review. Surg Today 2016;46:1045-52. [PMID: 26689209 DOI: 10.1007/s00595-015-1292-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
76 Kato S, Akimoto K, Nagashima Y, Ishiguro H, Kubota K, Kobayashi N, Hosono K, Watanabe S, Sekino Y, Sato T, Sasaki K, Nakaigawa N, Kubota Y, Inayama Y, Endo I, Ohno S, Maeda S, Nakajima A. aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology 2013;13:360-8. [PMID: 23890134 DOI: 10.1016/j.pan.2013.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
77 Law JK, Hruban RH, Lennon AM. Management of pancreatic cysts: a multidisciplinary approach. Curr Opin Gastroenterol. 2013;29:509-516. [PMID: 23872487 DOI: 10.1097/mog.0b013e328363e3b3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
78 Jabbar KS, Verbeke C, Hyltander AG, Sjövall H, Hansson GC, Sadik R. Response. J Natl Cancer Inst 2014;106:dju330. [PMID: 25359854 DOI: 10.1093/jnci/dju330] [Reference Citation Analysis]
79 Nilsson LN, Keane MG, Shamali A, Millastre Bocos J, Marijinissen van Zanten M, Antila A, Verdejo Gil C, Del Chiaro M, Laukkarinen J. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature. Pancreatology. 2016;16:1028-1036. [PMID: 27681503 DOI: 10.1016/j.pan.2016.09.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
80 Larson A, Kwon RS. Natural History of Pancreatic Cysts. Dig Dis Sci 2017;62:1770-7. [PMID: 28315034 DOI: 10.1007/s10620-017-4542-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
81 Yoon WJ, Brugge WR. Pancreatic cystic neoplasms: diagnosis and management. Gastroenterol Clin North Am. 2012;41:103-118. [PMID: 22341252 DOI: 10.1016/j.gtc.2011.12.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
82 Hirono S, Yamaue H. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas. Surg Today 2020;50:50-5. [PMID: 31807871 DOI: 10.1007/s00595-019-01931-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
83 Baker ML, Seeley ES, Pai R, Suriawinata AA, Mino-Kenudson M, Zamboni G, Klöppel G, Longnecker DS. Invasive mucinous cystic neoplasms of the pancreas. Exp Mol Pathol 2012;93:345-9. [PMID: 22902940 DOI: 10.1016/j.yexmp.2012.07.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
84 Ivry SL, Sharib JM, Dominguez DA, Roy N, Hatcher SE, Yip-Schneider MT, Schmidt CM, Brand RE, Park WG, Hebrok M, Kim GE, O'Donoghue AJ, Kirkwood KS, Craik CS. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clin Cancer Res 2017;23:4865-74. [PMID: 28424202 DOI: 10.1158/1078-0432.CCR-16-2987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
85 Salom F, Prat F. Current indications and yield of endoscopic ultrasound and ancillary techniques in pancreatic cystic neoplasms. Clin J Gastroenterol 2019;12:93-101. [PMID: 30565189 DOI: 10.1007/s12328-018-00930-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
86 Ethun CG, Postlewait LM, McInnis MR, Merchant N, Parikh A, Idrees K, Isom CA, Hawkins W, Fields RC, Strand M, Weber SM, Cho CS, Salem A, Martin RCG, Scoggins CR, Bentrem D, Kim HJ, Carr J, Ahmad SA, Abbott DE, Wilson G, Kooby DA, Maithel SK. The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 years. J Surg Oncol 2017;115:784-7. [PMID: 28211072 DOI: 10.1002/jso.24582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
87 Walsh RM, Perlmutter BC, Adsay V, Reid MD, Baker ME, Stevens T, Hue JJ, Hardacre JM, Shen GQ, Simon R, Aleassa EM, Augustin T, Eckhoff A, Allen PJ, Goh BKP. Advances in the management of pancreatic cystic neoplasms. Curr Probl Surg 2021;58:100879. [PMID: 34144739 DOI: 10.1016/j.cpsurg.2020.100879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Robinson S, Scott J, Oppong K, White S. What to do for the incidental pancreatic cystic lesion? Surgical Oncology 2014;23:117-25. [DOI: 10.1016/j.suronc.2014.04.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
89 Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, Castillo CF, Schmidt CM, Brugge WR, Layfield LJ. Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines. Cytojournal. 2014;11:3. [PMID: 25191517 DOI: 10.4103/1742-6413.133343] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
90 Honselmann KC, Patino M, Mino-Kenudson M, Ferrone C, Warshaw AL, Castillo CF, Lillemoe KD. Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch-duct IPMN After 10 Years of Surveillance. Ann Surg. 2017;266:e38-e40. [PMID: 28338512 DOI: 10.1097/sla.0000000000002238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
91 Kim YI, Shin SH, Song KB, Hwang DW, Lee JH, Park KM, Lee YJ, Kim SC. Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection. Korean J Hepatobiliary Pancreat Surg 2015;19:113-20. [PMID: 26379733 DOI: 10.14701/kjhbps.2015.19.3.113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
92 Falconi M, Crippa S, Chari S, Conlon K, Kim S, Levy P, Tanaka M, Werner J, Wolfgang CL, Pezzilli R, Castillo CF. Quality assessment of the guidelines on cystic neoplasms of the pancreas. Pancreatology 2015;15:463-9. [DOI: 10.1016/j.pan.2015.05.478] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
93 Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:824-48.e22. [PMID: 25805376 DOI: 10.1053/j.gastro.2015.01.014] [Cited by in Crossref: 208] [Cited by in F6Publishing: 161] [Article Influence: 29.7] [Reference Citation Analysis]
94 Wada K, Takaori K, Traverso LW. Screening for Pancreatic Cancer. Surg Clin North Am. 2015;95:1041-1052. [PMID: 26315522 DOI: 10.1016/j.suc.2015.05.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
95 Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Sigel C, Iacobuzio-Donahue C, Klimstra DS. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. Mod Pathol 2016;29:1058-69. [PMID: 27282351 DOI: 10.1038/modpathol.2016.98] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
96 Scholten L, van Huijgevoort NC, Bruno MJ, Fernandez–del Castillo C, Satoi S, Sauvanet A, Wolfgang C, Fockens P, Chari ST, Del Chiaro M, van Hooft JE, Besselink MG. Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study. Surgery 2018;164:17-23. [DOI: 10.1016/j.surg.2018.01.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
97 Pitman MB, Brugge WR, Warshaw AL. The value of cyst fluid analysis in the pre-operative evaluation of pancreatic cysts. J Gastrointest Oncol. 2011;2:195-198. [PMID: 22811850 DOI: 10.3978/j.issn.2078-6891.2011.044] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
98 Li Y, Zhu Z, Peng L, Jin Z, Sun L, Song B. The pathological features and prognoses of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm after surgical resection: a single institution series. World J Surg Oncol. 2020;18:287. [PMID: 33148260 DOI: 10.1186/s12957-020-02063-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Martin-Richard M, Ginès A, Ayuso JR, Sabater L, Fabregat J, Mendez R, Fernández-Esparrach G, Molero X, Vaquero EC, Cuatrecasas M, Ferrández A, Maurel J; Comité multidisciplinar para la actualización de las recomendaciones para el manejo de las lesiones pre-malignas y el adenocarcinoma de páncreas. [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. Med Clin (Barc) 2016;147:465.e1-8. [PMID: 27726847 DOI: 10.1016/j.medcli.2016.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
100 Perez-Johnston R, Narin O, Mino-Kenudson M, Ingkakul T, Warshaw AL, Fernandez-Del Castillo C, Sahani VD. Frequency and significance of calcification in IPMN. Pancreatology. 2013;13:43-47. [PMID: 23395569 DOI: 10.1016/j.pan.2012.11.306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
101 Fan Z, Cheng H, Jin K, Gong Y, Huang Q, Xu J, Ni Q, Yu X, Liu C, Luo G. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN. World J Surg Oncol. 2019;17:137. [PMID: 31387646 DOI: 10.1186/s12957-019-1682-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Crippa S, Capurso G, Cammà C, Fave GD, Castillo CF, Falconi M. Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis. Dig Liver Dis 2016;48:473-9. [PMID: 26965783 DOI: 10.1016/j.dld.2016.02.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
103 Xiao HD, Yamaguchi H, Dias-Santagata D, Kuboki Y, Akhavanfard S, Hatori T, Yamamoto M, Shiratori K, Kobayashi M, Shimizu M, Fernandez-Del Castillo C, Mino-Kenudson M, Furukawa T. Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 2011;224:508-16. [PMID: 21547907 DOI: 10.1002/path.2875] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
104 Buerlein RCD, Shami VM. Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know. Ther Adv Gastrointest Endosc 2021;14:26317745211045769. [PMID: 34589706 DOI: 10.1177/26317745211045769] [Reference Citation Analysis]
105 Kim JY, Hong S. Precursor Lesions of Pancreatic Cancer. Oncol Res Treat 2018;41:603-10. [DOI: 10.1159/000493554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
106 Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Lett 2020;469:228-37. [PMID: 31629933 DOI: 10.1016/j.canlet.2019.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
107 Castellano-Megías VM, Andrés CID, López-Alonso G, Colina-Ruizdelgado F. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol 2014; 6(9): 311-324 [PMID: 25232456 DOI: 10.4251/wjgo.v6.i9.311] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
108 Pitman MB. Pancreatic cyst fluid triage: A critical component of the preoperative evaluation of pancreatic cysts. Cancer Cytopathology 2013;121:57-60. [DOI: 10.1002/cncy.21227] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
109 Kaiser J, Scheifele C, Hinz U, Leonhardt C, Hank T, Koenig A, Tjaden C, Hackert T, Bergmann F, Büchler MW, Strobel O. IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy. European Journal of Surgical Oncology 2021. [DOI: 10.1016/j.ejso.2021.12.009] [Reference Citation Analysis]
110 Al–haddad M, Schmidt MC, Sandrasegaran K, Dewitt J. Diagnosis and Treatment of Cystic Pancreatic Tumors. Clinical Gastroenterology and Hepatology 2011;9:635-48. [DOI: 10.1016/j.cgh.2011.03.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
111 Ray Choudhury S, Mohanty S, Mohapatra D, Sahoo N, Panda A. An Atypical Presentation of Pancreatic Pseudocyst Masquerading as Solid Pseudopapillary Neoplasm of Pancreas. Cureus 2020;12:e9883. [PMID: 32968549 DOI: 10.7759/cureus.9883] [Reference Citation Analysis]
112 Matthaei H, Schulick RD, Hruban RH, Maitra A. Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2011;8:141-150. [PMID: 21383670 DOI: 10.1038/nrgastro.2011.2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 10.3] [Reference Citation Analysis]
113 Dudeja V, Allen PJ. Premalignant Cystic Neoplasms of the Pancreas. Seminars in Oncology 2015;42:70-85. [DOI: 10.1053/j.seminoncol.2014.12.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
114 Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, Warshaw AL, Lillemoe KD, Fernández-del Castillo C. Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype. Surgery 2015;158:1219-25. [PMID: 26077509 DOI: 10.1016/j.surg.2015.04.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
115 Hackert T, Fritz S, Klauss M, Bergmann F, Hinz U, Strobel O, Schneider L, Büchler MW. Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm. Ann Surg 2015;262:875-80; discussion 880-1. [PMID: 26583679 DOI: 10.1097/SLA.0000000000001462] [Cited by in Crossref: 73] [Cited by in F6Publishing: 20] [Article Influence: 12.2] [Reference Citation Analysis]
116 Morales-Oyarvide V, Fong ZV, Fernández-Del Castillo C, Warshaw AL. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations. Visc Med 2017;33:466-76. [PMID: 29344522 DOI: 10.1159/000485014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
117 Pergolini I, Schorn S, Jäger C, Göß R, Novotny A, Friess H, Ceyhan GO, Demir IE. Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis. Surgery 2021;169:411-8. [PMID: 32838986 DOI: 10.1016/j.surg.2020.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Manfredi R, Ventriglia A, Mantovani W, Mehrabi S, Boninsegna E, Zamboni G, Salvia R, Pozzi Mucelli R. Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization. Eur Radiol. 2015;25:940-949. [PMID: 25417125 DOI: 10.1007/s00330-014-3493-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
119 Satoh T, Ishiwatari H, Kawaguchi S, Sato J, Kaneko J, Kanemoto H, Sugiura T, Sasaki K, Matsubayashi H, Uesaka K, Ono H. Can regular follow-up imaging contribute to the determination of appropriate timing of surgery in patients with undiagnosed mucinous cystic neoplasm? A multicenter retrospective study. Jpn J Clin Oncol 2021:hyab103. [PMID: 34212179 DOI: 10.1093/jjco/hyab103] [Reference Citation Analysis]
120 Mayerle J, Kraft M, Menges P, Simon P, Ringel J, Partecke LI, Heidecke CD, Lerch MM. [Intraductal papillary mucinous neoplasia: which findings support observation?]. Chirurg. 2012;83:123-129. [PMID: 22271054 DOI: 10.1007/s00104-011-2183-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Roch AM, DeWitt JM, Al-Haddad MA, Schmidt CM 2nd, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. J Am Coll Surg 2014;219:122-9. [PMID: 24862887 DOI: 10.1016/j.jamcollsurg.2014.03.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
122 Kim YI, Woo SM, Lee WJ, Han SS, Park SJ, Kim TH, Koh YH, Hong EK. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas. Scand J Gastroenterol. 2013;48:610-616. [PMID: 23597152 DOI: 10.3109/00365521.2013.782065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
123 Panteleev VI, Kaldarov AR, Gorin DS, Kriger AG. [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors]. Khirurgiia (Mosk) 2021;:80-3. [PMID: 33570359 DOI: 10.17116/hirurgia202102180] [Reference Citation Analysis]
124 Dunne RF, Hezel AF. Genetics and Biology of Pancreatic Ductal Adenocarcinoma. Hematol Oncol Clin North Am 2015;29:595-608. [PMID: 26226899 DOI: 10.1016/j.hoc.2015.04.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
125 Marsoner K, Haybaeck J, Csengeri D, Waha JE, Schagerl J, Langeder R, Mischinger HJ, Kornprat P. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience. BMC Cancer 2016;16:844. [PMID: 27809876 DOI: 10.1186/s12885-016-2887-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
126 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Tjaden C, Sandini M, Mihaljevic AL, Kaiser J, Khristenko E, Mayer P, Hinz U, Gaida MM, Berchtold C, Diener MK, Schneider M, Mehrabi A, Müller-Stich BP, Strobel O, Hackert T, Büchler MW. Risk of the Watch-and-Wait Concept in Surgical Treatment of Intraductal Papillary Mucinous Neoplasm. JAMA Surg 2021;156:818-25. [PMID: 34009233 DOI: 10.1001/jamasurg.2021.0950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
128 Hinton J, Callan R, Bodine C, Glasgow W, Brower S, Jiang S, Li J. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas. Expert Review of Molecular Diagnostics 2014;13:431-43. [DOI: 10.1586/erm.13.38] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
129 Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, Wolfgang CL, Klein AP, Diaz LA Jr, Allen PJ, Schmidt CM, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011;3:92ra66. [PMID: 21775669 DOI: 10.1126/scitranslmed.3002543] [Cited by in Crossref: 544] [Cited by in F6Publishing: 491] [Article Influence: 54.4] [Reference Citation Analysis]
130 Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, Keller A, Habib NA, Stebbing J, Castellano L. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One. 2012;7:e32068. [PMID: 22384141 DOI: 10.1371/journal.pone.0032068] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 9.2] [Reference Citation Analysis]
131 Felix K, Honda K, Nagashima K, Kashiro A, Takeuchi K, Kobayashi T, Hinterkopf S, Gaida MM, Dang H, Brindl N, Kaiser J, Büchler MW, Strobel O. Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms. Int J Cancer 2021. [PMID: 34778955 DOI: 10.1002/ijc.33875] [Reference Citation Analysis]
132 Maitra A. Tracking down the hedgehog's lair in the pancreas. Gastroenterology 2010;138:823-5. [PMID: 20100446 DOI: 10.1053/j.gastro.2010.01.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
133 Werner J, Fritz S, Büchler MW. Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol 2012;9:253-9. [PMID: 22392299 DOI: 10.1038/nrgastro.2012.31] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
134 Lee SJ, Park SY, Hwang DW, Lee JH, Song KB, Lee W, Kwon J, Park Y, Kim SC. Surgical Decisions Based on a Balance between Malignancy Probability and Surgical Risk in Patients with Branch and Mixed-Type Intraductal Papillary Mucinous Neoplasm. J Clin Med 2020;9:E2758. [PMID: 32858841 DOI: 10.3390/jcm9092758] [Reference Citation Analysis]
135 Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang J, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97. [DOI: 10.1016/j.pan.2012.04.004] [Cited by in Crossref: 1540] [Cited by in F6Publishing: 1233] [Article Influence: 154.0] [Reference Citation Analysis]
136 Overbeek KA, Alblas M, Gausman V, Kandel P, Schweber AB, Brooks C, Van Riet PA, Wallace MB, Gonda TA, Cahen DL, Bruno MJ. Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression.Aliment Pharmacol Ther. 2019;50:789-799. [PMID: 31429105 DOI: 10.1111/apt.15440] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
137 Crippa S, Pergolini I, Rubini C, Castelli P, Partelli S, Zardini C, Marchesini G, Zamboni G, Falconi M. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms. Surgery 2016;159:1041-9. [DOI: 10.1016/j.surg.2015.11.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
138 Enestvedt BK, Ahmad N. To cease or ‘de-cyst’? The evaluation and management of pancreatic cystic lesions. Curr Gastroenterol Rep. 2013;15:348. [PMID: 24014118 DOI: 10.1007/s11894-013-0348-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
139 Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019;156:2024-2040. [PMID: 30721664 DOI: 10.1053/j.gastro.2019.01.259] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 47.3] [Reference Citation Analysis]
140 Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Sahani DV, Pergolini I, Negreros-Osuna AA, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma. Pancreatology 2017;17:920-6. [PMID: 28890154 DOI: 10.1016/j.pan.2017.08.073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
141 Tanaka M. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma. Pancreas. 2018;47:544-550. [PMID: 29702531 DOI: 10.1097/mpa.0000000000001047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
142 Cooper CL, O'Toole SA, Kench JG. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology 2013;45:286-304. [PMID: 23442735 DOI: 10.1097/PAT.0b013e32835f2205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
143 Fong ZV, Castillo CF. Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy. Viszeralmedizin 2015;31:43-6. [PMID: 26288615 DOI: 10.1159/000373912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
144 Klöppel G, Basturk O, Schlitter AM, Konukiewitz B, Esposito I. Intraductal neoplasms of the pancreas. Seminars in Diagnostic Pathology 2014;31:452-66. [DOI: 10.1053/j.semdp.2014.08.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
145 Welinsky S, Lucas AL. Familial Pancreatic Cancer and the Future of Directed Screening. Gut Liver 2017;11:761-70. [PMID: 28609837 DOI: 10.5009/gnl16414] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
146 Kang MJ, Jang JY, Lee S, Park T, Lee SY, Kim SW. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct. World J Surg. 2015;39:2006-2013. [PMID: 25894399 DOI: 10.1007/s00268-015-3062-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
147 Chiarelli M, Gerosa M, Tagliabue F, Fumagalli L, Guttadauro A, Gabrielli F, Marando A, De Simone M, Cioffi U. Left-sided pancreatic incidentalomas treated with laparoscopic approach: a report of 20 cases. World J Surg Onc 2016;14. [DOI: 10.1186/s12957-016-0949-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
148 Farrell JJ. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions. Gut Liver. 2015;9:571-589. [PMID: 26343068 DOI: 10.5009/gnl15063] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 13.8] [Reference Citation Analysis]
149 Greer JB, Ferrone CR. Spectrum and Classification of Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am 2016;25:339-50. [PMID: 27013368 DOI: 10.1016/j.soc.2015.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 Gardner TB, Glass LM, Smith KD, Ripple GH, Barth RJ, Klibansky DA, Colacchio TA, Tsapakos MJ, Suriawinata AA, Tsongalis GJ, Pipas JM, Gordon SR. Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol 2013;108:1546-50. [PMID: 24091499 DOI: 10.1038/ajg.2013.103] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
151 Noë M, Brosens LA. Pathology of Pancreatic Cancer Precursor Lesions. Surgical Pathology Clinics 2016;9:561-80. [DOI: 10.1016/j.path.2016.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
152 Aldaoud N, Joudeh A, Al-momen S, Alnahawi M, Al-abbadi MA. Anaplastic Carcinoma Arising in a Mucinous Cystic Neoplasm Masquerading as Pancreatic Pseudocyst: AC Arising in MCN of Pancreas Mimicking Pseudocyst. Diagn Cytopathol 2016;44:538-42. [DOI: 10.1002/dc.23473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
153 Crippa S, Arcidiacono PG, De Cobelli F, Falconi M. Review of the diagnosis and management of intraductal papillary mucinous neoplasms. United European Gastroenterol J 2020;8:249-55. [PMID: 32213017 DOI: 10.1177/2050640619894767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Weissman S, Thaker R, Zeffren N, Sarfaraz R, Dedousis J. Intraductal Papillary Mucinous Neoplasm of the Pancreas: Understanding the Basics and Beyond. Cureus 2019;11:e3867. [PMID: 30899618 DOI: 10.7759/cureus.3867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Roch AM, Bigelow K, Schmidt CM 2nd, Carr RA, Jester AL, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma. J Am Coll Surg 2017;224:717-23. [PMID: 28126546 DOI: 10.1016/j.jamcollsurg.2016.12.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
156 Boot C. A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions. Ann Clin Biochem. 2014;51:151-166. [PMID: 24097809 DOI: 10.1177/0004563213503819] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
157 Jabbar KS, Verbeke C, Hyltander AG, Sjövall H, Hansson GC, Sadik R. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. J Natl Cancer Inst. 2014;106:djt439. [PMID: 24523528 DOI: 10.1093/jnci/djt439] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
158 Das KK, Xiao H, Geng X, Fernandez-Del-Castillo C, Morales-Oyarvide V, Daglilar E, Forcione DG, Bounds BC, Brugge WR, Pitman MB, Mino-Kenudson M, Das KM. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN). Gut. 2014;63:1626-1634. [PMID: 24277729 DOI: 10.1136/gutjnl-2013-306219] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
159 Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, Fernandez-del Castillo C, Max Schmidt C, Brugge W, Layfield L;  Papanicolaou Society of Cytopathology. Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol. 2014;42:338-350. [PMID: 24554455 DOI: 10.1002/dc.23092] [Cited by in Crossref: 120] [Cited by in F6Publishing: 104] [Article Influence: 15.0] [Reference Citation Analysis]
160 Brugge WR. Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol. 2015;6:375-388. [PMID: 26261724 DOI: 10.3978/j.issn.2078-6891.2015.057] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
161 Nadig SN, Pedrosa I, Goldsmith JD, Callery MP, Vollmer CM. Clinical implications of mucinous nonneoplastic cysts of the pancreas. Pancreas. 2012;41:441-446. [PMID: 22015974 DOI: 10.1097/mpa.0b013e318229b9b8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
162 van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, van Hooft JE, Besselink MG. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019;16:676-689. [PMID: 31527862 DOI: 10.1038/s41575-019-0195-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
163 Marchegiani G, Mino-Kenudson M, Sahora K, Morales-Oyarvide V, Thayer S, Ferrone C, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg 2015;261:976-83. [PMID: 24979607 DOI: 10.1097/SLA.0000000000000813] [Cited by in Crossref: 70] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
164 Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol. 2011;8:56-60. [PMID: 21212775 DOI: 10.1038/nrgastro.2010.193] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
165 Miwa H, Sugimori K, Ishii T, Funaoka A, Tsuchiya H, Suzuki Y, Sugimori M, Nishimura M, Tozuka Y, Komiyama S, Sato T, Kaneko T, Numata K, Maeda S. Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas. Intern Med 2021;60:2607-12. [PMID: 33642489 DOI: 10.2169/internalmedicine.6755-20] [Reference Citation Analysis]
166 Das KK, Mullady DK. Main Pancreatic Duct Dilation in IPMN: When (and Where) to Get "Worried"? Clin Gastroenterol Hepatol 2021:S1542-3565(21)00151-8. [PMID: 33581356 DOI: 10.1016/j.cgh.2021.02.017] [Reference Citation Analysis]
167 Singhi AD, Nikiforova MN, McGrath K. DNA testing of pancreatic cyst fluid: is it ready for prime time? Lancet Gastroenterol Hepatol. 2017;2:63-72. [PMID: 28404017 DOI: 10.1016/s2468-1253(16)30084-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
168 Arshad HM, Bharmal S, Duman DG, Liangpunsakul S, Turner BG. Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions. J Investig Med. 2017;65:7-14. [PMID: 27574295 DOI: 10.1136/jim-2016-000167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
169 Yoshioka T, Shigekawa M, Yamai T, Suda T, Kegasawa T, Iwahashi K, Ikezawa K, Sakamori R, Yakushijin T, Hiramatsu N. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients. Pancreatology. 2016;16:1020-1027. [PMID: 27567445 DOI: 10.1016/j.pan.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
170 Tomishima K, Sai JK, Kanazawa R, Miura H, Shimizu R, Sato K, Ishii S, Saito H, Ito T, Fukumura Y, Shiina S, Watanabe S. Impact of MUC1 Expression on the Progression of Intraductal Papillary Mucinous Neoplasm With Worrisome Features During Follow-up. Pancreas 2017;46:1127-32. [DOI: 10.1097/mpa.0000000000000902] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
171 Kang JS, Park T, Han Y, Lee S, Lim H, Kim H, Kim SH, Kwon W, Kim SW, Jang JY. Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas. Ann Surg Treat Res. 2019;97:58-64. [PMID: 31388508 DOI: 10.4174/astr.2019.97.2.58] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
172 Xie T, Wang X, Zhang Z, Zhou Z. CT-Based Radiomics Analysis for Preoperative Diagnosis of Pancreatic Mucinous Cystic Neoplasm and Atypical Serous Cystadenomas. Front Oncol 2021;11:621520. [PMID: 34178619 DOI: 10.3389/fonc.2021.621520] [Reference Citation Analysis]
173 Hoshi H, Zaheer A, El Abiad RG, Maxwell JE, Chu LC, Gerke H, Chan CH. Management of pancreatic intraductal papillary mucinous neoplasm. Current Problems in Surgery 2018;55:126-52. [DOI: 10.1067/j.cpsurg.2018.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
174 Pizzi M, Pennelli G, Merante-Boschin I, Fassan M, Pelizzo MR, Rugge M. Pancreatic mucinous cystic tumor in Turner syndrome: How a tumor bends to a genetic disease. Int J Surg Case Rep 2013;4:1028-31. [PMID: 24096346 DOI: 10.1016/j.ijscr.2013.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
175 Li F, Malli A, Cruz-Monserrate Z, Conwell DL, Krishna SG. Confocal endomicroscopy and cyst fluid molecular analysis: Comprehensive evaluation of pancreatic cysts. World J Gastrointest Endosc 2018; 10(1): 1-9 [PMID: 29375735 DOI: 10.4253/wjge.v10.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
176 Rosenblatt R, Dorfman V, Epelboym I, Poneros JM, Sethi A, Lightdale C, Woo Y, Gress FG, Allendorf JD, Schrope BA, Chabot JA, Gonda TA. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms. Pancreas 2015;44:478-83. [PMID: 25411806 DOI: 10.1097/MPA.0000000000000264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
177 Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J Gastroenterol 2014; 20(32): 11182-11198 [PMID: 25170203 DOI: 10.3748/wjg.v20.i32.11182] [Cited by in CrossRef: 160] [Cited by in F6Publishing: 141] [Article Influence: 20.0] [Reference Citation Analysis]
178 Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions. Gastroenterology 2019; 157: 720-730. e2. [PMID: 31175863 DOI: 10.1053/j.gastro.2019.05.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
179 Cunningham SC, Hruban RH, Schulick RD. Differentiating intraductal papillary mucinous neoplasms from other pancreatic cystic lesions. World J Gastrointest Surg 2010; 2(10): 331-336 [PMID: 21160839 DOI: 10.4240/wjgs.v2.i10.331] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
180 Karoumpalis I, Christodoulou DK. Cystic lesions of the pancreas. Ann Gastroenterol 2016;29:155-61. [PMID: 27065727 DOI: 10.20524/aog.2016.0007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
181 Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, Calculli L, Tamburrino D, Piccioli A, Ruffo G, Fave GD, Falconi M. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management. Am J Gastroenterol 2017;112:1153-61. [PMID: 28244498 DOI: 10.1038/ajg.2017.43] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
182 Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, Dewitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Invasive, mixed-type intraductal papillary mucinous neoplasm: Superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm. Surgery 2015;158:937-45. [DOI: 10.1016/j.surg.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
183 Pusateri AJ, Krishna SG. Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential. Diseases. 2018;6. [PMID: 29899320 DOI: 10.3390/diseases6020050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
184 Heidarian A, Das KK, Mino-Kenudson M, Fernandez-Del Castillo C, Pitman MB. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts. J Am Soc Cytopathol 2021;10:249-54. [PMID: 33541830 DOI: 10.1016/j.jasc.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Abel L, Wasserthal J, Weikert T, Sauter AW, Nesic I, Obradovic M, Yang S, Manneck S, Glessgen C, Ospel JM, Stieltjes B, Boll DT, Friebe B. Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning. Diagnostics (Basel) 2021;11:901. [PMID: 34069328 DOI: 10.3390/diagnostics11050901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, Levy P, Partelli S, Suleiman SL, Banks PA. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut. 2016; Epub ahead of print. [PMID: 26743012 DOI: 10.1136/gutjnl-2015-310162] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 20.0] [Reference Citation Analysis]
187 Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 2013;13:583-8. [PMID: 24280573 DOI: 10.1016/j.pan.2013.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
188 Ma G, Li G, Xiao Z, Gou A, Xu Y, Song S, Guo K, Liu Z. Narrative review of intraductal papillary mucinous neoplasms: pathogenesis, diagnosis, and treatment of a true precancerous lesion. Gland Surg 2021;10:2313-24. [PMID: 34422602 DOI: 10.21037/gs-21-450] [Reference Citation Analysis]
189 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochim Biophys Acta Rev Cancer 2020;1873:188318. [PMID: 31676330 DOI: 10.1016/j.bbcan.2019.188318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
190 Crippa S, Aleotti F, Longo E, Belfiori G, Partelli S, Tamburrino D, Di Salvo F, De Cobelli F, Romano L, Arcidiacono PG, Petrone MC, Zamboni G, Lena MS, Doglioni C, Falconi M. Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31724-9. [PMID: 33385536 DOI: 10.1016/j.cgh.2020.12.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Boraschi P, Tarantini G, Donati F, Scalise P, Cervelli R, Caramella D. Side-branch intraductal papillary mucinous neoplasms of the pancreas: outcome of MR imaging surveillance over a 10 years follow-up. Eur J Radiol Open 2020;7:100250. [PMID: 32884981 DOI: 10.1016/j.ejro.2020.100250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Höhn P, Soydemir MA, Luu AM, Janot-Matuschek M, Tannapfel A, Uhl W, Belyaev O. It's not all about the size-characteristics and risk factors for malignancy of mucinous cystic neoplasms of the pancreas. Ann Transl Med 2020;8:1572. [PMID: 33437771 DOI: 10.21037/atm-20-4774] [Reference Citation Analysis]